Wells Fargo’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Wells Fargo’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85	Closed	-$25	–	7790
2023 Q3	$25	Sell	85 -11	-11%	-$6	﹤0.01%	7132
2023 Q2	$47	Buy	96 +20	+26%	+$13	﹤0.01%	7074
2023 Q1	$68	Buy	76 +24	+46%	+$30	﹤0.01%	7027
2022 Q4	$64	Sell	52 -6	-10%	-$9	﹤0.01%	6930
2022 Q3	$0	Buy	+58	New	+$139	﹤0.01%	7680

Wells Fargo's CMRA Position: Q4 2023 in Review

Wells Fargo sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 85 shares — an estimated $25 sold.

Wells Fargo first reported a position in CMRA in Q3 2022 and held it in 5 quarters. The position peaked at $68 in Q1 2023. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Wells Fargo reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 85 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $25.
Wells Fargo first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Wells Fargo's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $68 in Q1 2023.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.